首页> 外文期刊>Journal of Neurology Research >Effects of a PDGFR-a Antagonist Imatinib on Blood-Brain Barrier Disruption in Focal Cerebral Ischemia in Younger and Older Rats
【24h】

Effects of a PDGFR-a Antagonist Imatinib on Blood-Brain Barrier Disruption in Focal Cerebral Ischemia in Younger and Older Rats

机译:PDGFR-a拮抗剂伊马替尼对老年和老年大鼠局灶性脑缺血的血脑屏障破坏的影响

获取原文
       

摘要

Background: One of the pathways involving blood-brain barrier (BBB) disruption in focal ischemia can act through the platelet derived growth factor a receptor (PDGFR-a) system including PDGF-CC and tissue plasminogen activator (tPA). This study was performed to compare the effects of imatinib, a PDGFR-a antagonist, on blood-brain barrier (BBB) permeability in younger and older rats in focal cerebral ischemia and to determine whether the protein levels of PDGFR-a vary with age.?Methods: Three month old (Younger) and 24 month old (Older) male Fischer 344 rats were used. One hour before middle cerebral artery (MCA) occlusion, rats were treated by gavage with normal saline (control) or imatinib mesylate 200 mg/kg. At one and a half hours after MCA occlusion, BBB permeability was determined by measuring the transfer coefficient (Ki) of 14C-a-aminoisobutyric acid and volume of dextran distribution. Western blot analysis of PDGFR-a was performed on additional rats.?Results: With MCA occlusion, the Ki of the ischemic cortex (IC) significantly increased in both age groups. The Ki of the IC of the older control rats was significantly lower (-57%) than that of the younger control rats. In the younger rats, imatinib significantly decreased the Ki of the IC (-48%). In the older rats, however, imatinib failed to decrease the Ki. The difference in volume of dextran distribution between the IC and the contralateral cortex was significant only in the younger control rats and became insignificant with imatinib. Imatinib did not affect the volume of dextran distribution in the older rats. Neither aging nor imatinib affected BBB permeability in non-ischemic brain regions. The ratio of density of PDGFR-a normalized for tubulin level was similar between the younger and older rats (younger: 0.85 ± 0.48 vs older: 0.93 ± 0.58).?Conclusion: Imatinib decreased BBB disruption caused by focal cerebral ischemia in the younger rats but failed to decrease it in the older rats in spite of similar protein level of PDGFR-a.doi: http://dx.doi.org/10.4021/jnr118w
机译:背景:局灶性缺血中涉及血脑屏障(BBB)破坏的一种途径可以通过血小板衍生生长因子受体(PDGFR-a)系统起作用,包括PDGF-CC和组织纤溶酶原激活剂(tPA)。进行这项研究的目的是比较PDGFR-a拮抗剂伊马替尼对局灶性脑缺血幼小和老年大鼠血脑屏障(BBB)通透性的影响,并确定PDGFR-a的蛋白质水平是否随年龄而变化。方法:使用3个月大(年轻)和24个月大(较大)的Fischer 344大鼠。在大脑中动脉(MCA)闭塞前一小时,用生理盐水(对照组)或甲磺酸伊马替尼200 mg / kg进行管饲法治疗大鼠。在MCA闭塞后一个半小时,通过测量14C-α-氨基异丁酸的转移系数(Ki)和右旋糖酐的分布量来确定BBB的通透性。结果:在MCA闭塞的情况下,两个年龄组的缺血皮层(IC)的Ki值均显着增加。老年对照组大鼠IC的Ki值显着低于年轻对照组大鼠(-57%)。在年轻的大鼠中,伊马替尼显着降低了IC的Ki(-48%)。然而,在年长的大鼠中,伊马替尼未能降低Ki。 IC和对侧皮质之间的右旋糖酐分布量差异仅在较年轻的对照大鼠中显着,而对伊马替尼而言则微不足道。伊马替尼不影响老年大鼠的右旋糖酐分布量。老化和伊马替尼均未影响非缺血性脑区域的血脑屏障通透性。在年轻和老年大鼠中,标准化的微管蛋白水平的PDGFR-a的密度比相似(年轻人:0.85±0.48,而老年:0.93±0.58)。结论:伊马替尼减少了年轻大鼠局灶性脑缺血引起的BBB破坏。尽管PDGFR-a.doi的蛋白质水平相似,但在老年大鼠中未能降低它:http://dx.doi.org/10.4021/jnr118w

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号